
Japan’s Shionogi, creator of the blockbuster cholesterol treatment Crestor, announced on Monday, March 30, it would tie up with Ping An Insurance Group of China, selling a 2.05% voting stake for 33.53 billion yen (US$311 million).
Shionogi will form a joint venture with the Chinese group’s unit, Ping An Life Insurance of China Ltd, with the aim of discovering and distributing new drugs and developing generic ones as it looks to expand in China, reported Reuters.
“To attain our growth strategy beyond 2020, we must realize the expansion of our business in China, which is expected to show the greatest pharmaceutical market growth in the world over the next 10 years,” Shionogi said in the statement.
Shionogi, which gains roughly half its revenue from royalties, posted four-straight years of record operating profit through 2019. It focuses on infectious diseases but a looming patent cliff for its HIV treatments will create an earnings gap that will be hard to completely offset.
Ping An Insurance Group, China’s largest insurer by market value, said in February it expected the coronavirus outbreak to affect its business in the first half.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Dollar Tree to Sell Family Dollar for $1 Billion, Ending Struggling Merger
Mar 26, 2025 by
CPI
Meta Platforms Defends Use of Authors’ Works in AI Training in US Court
Mar 26, 2025 by
CPI
EU Pressed Meta to Address Antitrust Concerns Over Facebook Marketplace
Mar 26, 2025 by
CPI
UBS, Nomura, and UniCredit Fail to Overturn EU Antitrust Fines in Bond Trading Cartel Case
Mar 26, 2025 by
CPI
Coca-Cola Among Firms Targeted in EU Antitrust Raids
Mar 26, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mobile Ecosystems
Mar 24, 2025 by
CPI
Mobile Ecosystems: An Intellectual Entelechy but A Necessary Model
Mar 24, 2025 by
Alba Ribera Martinez
Creating Contestability and Fairness in Mobile Ecosystems: The Contribution of the DMA
Mar 24, 2025 by
Damien Geradin & Daniel Mandrescu
Digital Ecosystems and the Not (Yet) As Efficient Competitor Principle
Mar 24, 2025 by
Thomas Hoppner & Philipp Westerhoff
Assessing the Competition Law Scrutiny of Smart Wearables and Mobile AR/VR Devices
Mar 24, 2025 by
Kayvan Hazemi-Jebelli